Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerationsPart III: The chronic leukemias and myelofibrosis

被引:0
作者
D. Quaglino
G. Di Leonardo
N. Furia
E. Pasqualoni
A. Campitelli
机构
[1] Università degli Studi,Dipartimento di Medicina Interna e Sanità Pubblica
来源
Aging Clinical and Experimental Research | 1997年 / 9卷
关键词
Chronic leukemias; elderly; myelofibrosis; myeloid metaplasia;
D O I
暂无
中图分类号
学科分类号
摘要
The different therapeutic options available for the treatment of chronic leukemias and myelofibrosis are discussed. In reference to chronic myeloid leukemia (CML), the choice of the most appropriate treatment must take into account not only the clinical condition but also the age of the patient. While subjects under 50 might benefit from the options offered by α-interferon, bone marrow and peripheral stem cell transplant, in older age groups treatment of the chronic phase must still rely on standard treatment. Chronic lymphocytic leukemia (CLL) and its variants is a disease of mostly middle and late life, with a variable clinical course. Patients show wide differences in morbidity and mortality. Many features have been shown to influence the prognosis, and the most important ones are incorporated into the staging systems currently in use. The results obtained from the study of large trials support the concept that treatment of patients with stable stage A CLL should be postponed until progression of disease. Treatment relies principally on alkylating agents, corticosteroids and radiation therapy; the new nucleoside analogues, such as fludarabine and 2-chlo ro de oxyadenosine, have recently acquired established value in improving overall survival. With regard to myelofibrosis, the histological and biological features that influence the natural course of the disease are described, as well as the choice of the most appropriate treatment, which ranges from the use of alkylating agents and androgens, to splenectomy and splenic irradiation.
引用
收藏
页码:383 / 390
页数:7
相关论文
共 211 条
[1]  
Champlin RE(1988)Bone marrow transplantation in chronic myelogenous leukaemia Semin. Haematol 25 74-80
[2]  
Goldman JM(1988)Bone marrow transplantation for chronic myelogenous leukaemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann. Intern. Med 108 806-814
[3]  
Gale RP(1969)Chemotherapy of chronic myelocytic leukaemia Semin. Hematol 6 323-343
[4]  
Goldman JM(1966)Hydroxyurea in chronic myeloid leukaemia JAMA 195 1038-1044
[5]  
Gale RP(1975)Hydroxyurea in the management of the haematologic complications of chronic granulocytic leukaemia Blood 46 11-16
[6]  
Horowitz MM(1986)Chronic myelogenous leukaemia: haematological remission with alpha-interferon Br. J. Haematol 64 87-95
[7]  
Biggs JC(1987)Clinical investigation of human alpha interferon in chronic myelogenous leukaemia Blood 5 1280-1288
[8]  
Champling RE(1984)Benign monoclonal B cell Lymphocytosis-a benign variant of CLL: clinical, immunologic, phenotypic and cytogenetic studies in 20 patients Blood 64 244-252
[9]  
Gluckman E(1975)Clinical staging of chronic lymphocytic leukaemia Blood 46 219-234
[10]  
Hoffman RG(1981)A new prognostic classification of chronic lymphocytic leukaemia derived from a multivariate survival analysis Cancer 48 198-206